New York
ImClone Systems founder Sam Waksal—a close friend of Martha Stewart—became the latest casualty of the corporate scandals this week, pleading guilty to bank fraud, conspiracy, and perjury. Waksal, prosecutors said, warned family members to sell ImClone stock when he discovered that federal regulators would reject the company’s new cancer drug. Stewart also sold off 4,000 ImClone shares before the stock plummeted, and is apparently a target of a continuing insider-trading investigation. Douglas Faneuil, an assistant to Stewart’s stockbroker, pleaded guilty to a misdemeanor charge earlier this month and agreed to testify for the prosecution.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
The ‘ravenous’ demand for Cornish mineralsUnder the Radar Growing need for critical minerals to power tech has intensified ‘appetite’ for lithium, which could be a ‘huge boon’ for local economy
-
Why are election experts taking Trump’s midterm threats seriously?IN THE SPOTLIGHT As the president muses about polling place deployments and a centralized electoral system aimed at one-party control, lawmakers are taking this administration at its word
-
‘Restaurateurs have become millionaires’Instant Opinion Opinion, comment and editorials of the day
